Research Article
The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario
Table 1
Baseline characteristics and demographics of PAH cases in Ontario as of April 1, 2011.
| | | Total | Age < 65 | Age ≥ 65 | value
Age < 65 versus age ≥ 65 | | | | | |
| | Female ( (%)) | 251 (77%) | 127 (77%) | 124 (77%) | 0.992 | | Age (mean, SD) | 59.4 (20.3) | 43.4 (15.8) | 75.7 (6.7) | <0.001 | | Rural location of residence ( (%)) | 39 (12%) | 17 (10.3%) | 22 (13.7%) | 0.350 | | Income quintile ( (%)) | | | | | | 1 (lowest) | 77 (23.6%) | 42 (25.5%) | 35 (21.7%) | 0.430 | | 2 | 52 (16%) | 29 (17.6%) | 23 (14.3%) | 0.417 | | 3 | 64 (19.6%) | 31 (18.8%) | 33 (20.5%) | 0.698 | | 4 | 81 (24.9%) | 37 (22.4%) | 44 (27.3%) | 0.306 | | 5 (highest) | 52 (16%) | 26 (15.8%) | 26 (16.2%) | 0.923 | | Comorbidities ( (%)) | | | | | | Cardiovascular disease | 312 (95.7%) | 156 (94.6%) | 156 (96.9%) | 0.296 | | Heart failure | 72 (22.1%) | 33 (20%) | 39 (24.2%) | 0.358 | | Atrial fibrillation/flutter | 41 (12.6%) | 9 (5.5%) | 32 (19.9%) | 0.001 | | Respiratory disease | 154 (47.2%) | 56 (33.9%) | 98 (60.9%) | <0.001 | | Chronic obstructive pulmonary disease | 147 (45.1%) | 55 (33.3%) | 92 (57.1%) | <0.001 | | Connective tissue disease | 47 (14.4%) | 27 (16.4%) | 20 (12.4%) | 0.311 | | Other conditions | | | | | | Diabetes | 79 (24.2%) | 27 (16.4%) | 52 (32.3%) | <0.001 | | Thyroid disease | 17 (5.2%) | 10 (6.1%) | 7 (4.4%) | 0.487 | | Drug use (past 3 years) ( (%)) | | | | | | Antihypertensive | 145 (44.5%) | 49 (29.7%) | 96 (59.6%) | <0.001 | | Calcium channel blockers | 75 (23%) | 19 (11.5%) | 56 (34.8%) | <0.001 | | Oral anticoagulants | 125 (38.3%) | 53 (32.1%) | 72 (44.7%) | 0.019 | | Diuretics | 189 (58.0%) | 73 (44.2%) | 116 (72.1%) | <0.001 | | Digoxin | 25 (7.7%) | 9 (5.5%) | 16 (9.9%) | 0.128 |
|
|
